-
EP2440050
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2440050
| EP2440050 - TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.03.2015 Database last updated on 03.09.2024 | Most recent event Tooltip | 06.03.2015 | Application deemed to be withdrawn | published on 08.04.2015 [2015/15] | Applicant(s) | For all designated states California Capital Equity, LLC 11755 Wilshire Boulevard, Suite 2000 Los Angeles CA 90025 / US | [2012/27] |
| Former [2012/16] | For all designated states Abraxis BioScience, LLC 11755 Wilshire Boulevard Suite 2000 Los Angeles, CA 90025 / US | Inventor(s) | 01 /
TAO, Chunlin 1800 Camden Avenue, No.301 Los Angeles California 90025 / US | 02 /
WANG, Qinwei 1112 South Cordova Street Alhambra California 91801 / US | 03 /
NALLAN, Laxman 930 North Monterey Street, No.236 Alhambra California 91801 / US | 04 /
POLAT, Tulay 5750 West Centinela Avenue, No.224 Los Angeles California 90045 / US | 05 /
KORONIAK, Lukasz Chocimska 28 PL-60688 Poznan / PL | 06 /
DESAI, Neil 11755 Wilshire Boulevard Suite 2000 Los Angeles California 90025 / US | [2012/16] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstrasse 4 80802 München / DE | [N/P] |
| Former [2012/16] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE | Application number, filing date | 10786616.2 | 07.06.2010 | WO2010US37570 | Priority number, date | US20090185052P | 08.06.2009 Original published format: US 185052 P | [2012/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010144338 | Date: | 16.12.2010 | Language: | EN | [2010/50] | Type: | A1 Application with search report | No.: | EP2440050 | Date: | 18.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.12.2010 takes the place of the publication of the European patent application. | [2012/16] | Search report(s) | International search report - published on: | US | 16.12.2010 | (Supplementary) European search report - dispatched on: | EP | 01.03.2013 | Classification | IPC: | A01N43/66, A61K31/53 | [2012/16] | CPC: |
A61K31/53 (EP,US);
C07D417/14 (KR);
A61K31/427 (KR);
A61K45/06 (EP,US);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P17/02 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/10 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P27/06 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P5/14 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
A61P7/10 (EP);
A61P9/00 (EP);
A61P9/04 (EP);
| C-Set: |
A61K31/53, A61K2300/00 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/16] | Extension states | BA | 09.01.2012 | ME | 09.01.2012 | RS | 09.01.2012 | Title | German: | TRIAZINDERIVATE UND IHRE THERAPEUTISCHE ANWENDUNG | [2012/16] | English: | TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS | [2012/16] | French: | DÉRIVÉS DE TRIAZINE ET LEURS APPLICATIONS THÉRAPEUTIQUES | [2012/16] | Entry into regional phase | 09.01.2012 | National basic fee paid | 09.01.2012 | Search fee paid | 09.01.2012 | Designation fee(s) paid | 09.01.2012 | Examination fee paid | Examination procedure | 09.01.2012 | Examination requested [2012/16] | 27.09.2013 | Amendment by applicant (claims and/or description) | 17.06.2014 | Despatch of a communication from the examining division (Time limit: M04) | 28.10.2014 | Application deemed to be withdrawn, date of legal effect [2015/15] | 03.12.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/15] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.06.2014 | Fees paid | Renewal fee | 27.06.2012 | Renewal fee patent year 03 | 20.06.2013 | Renewal fee patent year 04 | 31.03.2014 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [IY]WO03078427 (VERTEX PHARMA [US], et al) [I] 1,2,4-9 * Abstract; claims; page 24, paragraphs 0060, 0062; pages 32, paragraph 0086; page 36, paragraph 0097; pages 37-38, paragraph 00102. * [Y] 1,2,4-9; | [IY]WO03078423 (VERTEX PHARMA [US], et al) [I] 1,2,4-9 * Abstract; claims; page 18, paragraph 0048; page 27, paragraphs 0064, 0066; pages 39-40, paragraphs 00102, 00106; * [Y] 1,2,4-9; | [XI]EP2036895 (CHUGAI PHARMACEUTICAL CO LTD [JP]) [X] 1,2,5,6,9 * Claims 1, 20-21; paragraphs 0055-0056; page 67, paragraph 0215: example 11. * [I] 4,7,8; | [XP]WO2009150462 (ASTRAZENECA AB [SE], et al) [XP] 1,2,4-9 * Abstract; claims; page 49, line 15 to page 50, line 12; page 57, lines 16-19; examples e.g. intermediates 62-63, examples 1-6, 8-12, 17-35. *; | [E]WO2010144359 (ABRAXIS BIOSCIENCE LLC [US], et al) [E] 1,2,4-9 * Claim 1; examples, e.g. page 79, example 13; page 96, example 47. *; | [E]WO2010144394 (ABRAXIS BIOSCIENCE LLC [US], et al) [E] 1,2,4-9 * Claim 1; examples, e.g. examples 2-4, 6-10, 12-13, 18-23. *; | [E]WO2010144522 (ABRAXIS BIOSCIENCE LLC [US], et al) [E] 1,2,4-9 * Claim 1; examples e.g. examples 6-7, 9-15, 21-25. *; | [E]WO2010144550 (ABRAXIS BIOSCIENCE LLC [US], et al) [E] 1,2,4-9 * Claim 1; examples e.g. page 71, example 20, page 75, example 27, pages 81-82, examples 36-37. *; | [X] - Reaxys, Elsevier Information Systems GmbH, Frankfurt/Main (DE), Database accession no. 6233290 (XRN), XP002691494 [X] 1 * further database accession nos. 6235031, 6236210, 6240637, 6250685, 6251448, 6254346, 6254991, 6255720, 6256669, 6257187, 6257437, 6258421, 6259633, 6260551, 6261684, 6276277, 6276795, 6279225, 6279915, 6280537, 6281033, 6281851, 6282206, 6284764, 6285164 (XRNs). * | [ ] - J. PRAKT. CHEMIE, (1987), vol. 329, no. 2, pages 259 - 270 | [X] - MIKHAILICHENKO ET AL., "sym-Triazines. 7. Hydrolysis and cyclization of 1,3,5-triazine series mononitriles", CHEMISTRY OF HETEROCYCLIC COMPOUNDS, (20060501), vol. 42, no. 5, doi:10.1007/S10593-006-0140-0, pages 642 - 647, XP019393545 [X] 1 * Page 646, scheme 2: compounds 8b, 8c. * DOI: http://dx.doi.org/10.1007/s10593-006-0140-0 | [XI] - Reaxys, Elsevier Information Systems GmbH, Frankfurt/Main (DE), Database accession no. 5584770 (XRN), XP002691495 [X] 1 * abstract * [I] 2 | [ ] - PHARMAZIE, (1989), vol. 44, no. 3, pages 191 - 193 | International search | [X]US2008176853 (TAO CHUNLIN [US], et al) |